The team at RA Capital Management has been investing since 2002 and is made up of professionals with training in biology, chemistry, and medicine as well as industry and business development experience. They invest in companies with promising technologies and products and aim to achieve a superior understanding of data, experimental/trial design, regulatory process, and commercial potential. RA Capital Management also offers portfolio companies leads on in-licensing opportunities and strategic partnerships, as well as insight into the demands of the public markets. The firm focuses on evidence-based investing in public and private healthcare and life science companies developing drugs, medical devices, services & research tools, and diagnostics sectors. They provide seed funding to startups and lead private, IPO, and follow-on financings for their portfolio companies, allowing management teams to drive value creation with fewer capital concerns from inception through commercialization. At RA Capital’s core is its TechAtlas research division, which provides strategic intelligence, market research, and other resources to the investment team and portfolio companies.